New heart valve device enters human testing
NCT ID NCT07450911
Summary
This early-stage study is testing a new device called the ReValve System to replace leaky mitral valves in the heart. The trial will enroll 20 adults with severe mitral regurgitation who are experiencing symptoms like shortness of breath and fatigue. Researchers will assess whether the device can be successfully implanted and reduce the severity of the valve leakage.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MITRAL REGURGITATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Healthycore
RECRUITINGTbilisi, Georgia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Tbilisi Heart and Vascular Center
RECRUITINGTbilisi, Georgia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Tiblisi Heart Center
RECRUITINGTbilisi, Georgia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.